Volume 33, Issue 224 ( 2023)                   J Mazandaran Univ Med Sci 2023, 33(224): 129-137 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Barani A, Khanalipour M H, Dalilian N, Farzin D, Ebrahimzadeh M A. Evaluation of Antihypoxic Activities of Colchicine. J Mazandaran Univ Med Sci 2023; 33 (224) :129-137
URL: http://jmums.mazums.ac.ir/article-1-19325-en.html
Abstract:   (526 Views)
 Background and purpose: Hypoxia can lead to body function impairment. It is linked to the pathology of acute mountain sickness, cardiovascular disease, and stroke. Colchicine, an anti-inflammatory drug, is used chiefly in treatment of gout, but it is also valuable in other inflammatory conditions. Preliminary data shows that colchicine has beneficial effects on COVID-19. Nothing is known about the protective effect of this drug against hypoxia-induced lethality in mice.
Materials and methods: Protective effects of colchicine against hypoxia-induced lethality in mice at 0.5, 1, and 1.5 mg/kg, P.O. were evaluated in three experimental models of hypoxia.
Results: Colchicine showed good activity in some models. In the circulatory model, at 0.5 mg/kg, it significantly prolonged mice survival time for 4.5 min (P<0.05). At this dose, it showed similar activity to propranolol 30 mg/kg which was used as the positive control. At 1.5 mg/kg, it was more effective than propranolol (P<0.0001). In the haemic antihypoxic model, colchicine at 1 mg/kg, significantly increased survival time and showed the same activity as propranolol (P>0.05). In the asphyctic model, colchicine did not show any activity.
Conclusion: Colchicine showed good protective effects against hypoxia in circulatory and haemic models where the drug at 1.5 mg/kg, was more effective than the positive control, propranolol at 30 mg/kg.
 
Full-Text [PDF 354 kb]   (251 Downloads)    
Type of Study: Brief Report | Subject: pharmacology

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb